‘Not ayurvedic’: CSIR on plant-based drug ACQH to be tested for Covid treatment
Updated on Jun 06, 2020 05:50 pm IST
Centre of Scientific and Industrial Research (CSIR) Director-General Dr Shekhar C Mande spoke on the clinical trials of phytopharmaceutical ACQH. “We're going to try it against Covid-19. It's historic in modern medicine, especially in India. We have a chance to tap our traditional knowledge system and its limitless possibilities,” he said. Indian drugmaker Sun Pharmaceutical Industries Ltd said on Friday it was testing a plant-derived drug, AQCH, for the potential treatment of Covid-19 as part of a mid-stage trial, with results expected by October. Watch the video to know more.
RELATED VIDEOS
India Silently Rushes Warships Near Houthi Territory After U.S. Forms Red Sea Force | Watch
Published on Dec 19, 2023 08:38 pm IST
India calls-out W.H.O Covid death data at Geneva; conveys ‘disappointment’
Published on May 24, 2022 07:41 am IST
Paid Covid booster doses for Indian adults: Prices, Availability | Key details
Published on Jul 25, 2023 03:21 pm IST
How Shanghai is grappling with biggest-ever Covid outbreak
Published on Apr 06, 2022 11:08 pm IST
XE a ‘recombinant’: What we know of the new Covid variant reported from Mumbai
Published on Apr 06, 2022 09:56 pm IST
PM Modi clarifies on migrant crisis; says, ‘States imposed lockdown first’
Published on Feb 10, 2022 09:08 am IST
Hi, {{name}}
Sign out
{{planName}}
{{^userSubscribed}}
{{/userSubscribed}}